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Bladder sensation is mediated by lumbosacral dorsal root ganglion neurons and is essential
for normal voiding and nociception. Numerous electrophysiological, structural, and
molecular changes occur in these neurons following inflammation. Defining which neurons
undergo these changes is critical for understanding the mechanism underlying bladder
pain and dysfunction. Our first aim was to define the chemical classes of bladder sensory
neurons that express receptors for the endogenous modulators of nociceptor sensitivity,
glial cell line-derived neurotrophic factor (GDNF), the related neurotrophic factor, artemin,
and estrogens. Bladder sensory neurons of adult female Sprague-Dawley rats were
identified with retrograde tracer. Diverse groups of neurons express these receptors, and
some neurons express receptors for both neurotrophic factors and estrogens. Lumbar
and sacral sensory neurons showed some distinct differences in their expression profile.
We also distinguished the chemical profile of myelinated and unmyelinated bladder
sensory neurons. Our second aim was to identify bladder sensory neurons likely to be
undergoing structural remodeling during inflammation. Following systemic administration
of cyclophosphamide (CYP), its renal metabolite acrolein causes transient urothelial loss,
exposing local afferent terminals to a toxic environment. CYP induced expression of the
injury-related immediate-early gene product, activating transcription factor-3 (ATF-3), in
a small population of sacral nitrergic bladder sensory neurons. In conclusion, we have
defined the bladder sensory neurons that express receptors for GDNF, artemin and
estrogens. Our study has also identified a sub-population of sacral sensory neurons that
are likely to be undergoing structural remodeling during acute inflammation of the bladder.
Together these results contribute to increased understanding of the neurons that are
known to be involved in pain modulation and hyperreflexia during inflammation.
Keywords: dorsal root ganglion, painful bladder syndrome, pelvic pain, visceral pain, steroid, cystitis, interstitial
cystitis, inflammatory pain
INTRODUCTION
Visceral pain is one of the most frequent types of pain seen in the
clinical setting. It is poorly localized, associated with referred pain
and is resistant to many analgesics that alleviate somatic pain.
Development of appropriate animal models of visceral pain is
challenging, but bladder inflammation models in rodents have
revealed many changes in bladder afferent pathways and their
targets in the lumbosacral spinal cord that underpin nociceptor
sensitization [reviewed in De Groat and Yoshimura (2009); Daly
et al. (2011); Kanai (2011)]. This sensitization is critically linked
to the initiation of pain and altered reflex behaviors, includ-
ing increased voiding frequency and a reduction in micturition
threshold, characteristics of clinical bladder inflammation.
One of the most thoroughly characterized rodent models of
bladder inflammatory pain is induced by the systemic adminis-
tration of cyclophosphamide (CYP), which is then metabolized
to acrolein that initiates inflammation of the lower urinary tract
(Cox, 1979; Maggi et al., 1992). Following either acute or chronic
CYP treatment, bladder afferent neurons undergo changes in
neuropeptide and ion channel expression, leading to altered
excitability and connectivity, together thought to drive sponta-
neous activity and increased sensitivity (Nazif et al., 2007; De
Groat and Yoshimura, 2009; Kanai, 2011). Defining which partic-
ular afferent neurons undergo these changes is critical to under-
standing the overall mechanism underlying pain and bladder
dysfunction.
Primary afferent neurons that innervate the bladder are
located in dorsal root ganglia (DRG). In rats these are aggre-
gated in spinal levels L1-L2 (“lumbar”) and L6-S1 (“sacral”)
(Keast and De Groat, 1992). These neurons can be identified
by applying retrograde tracer to the bladder in vivo, a num-
ber of days prior to removal of DRGs for analysis. Using this
approach, immunohistochemical studies have determined that
many of these neurons synthesize neuropeptides commonly asso-
ciated with sensory and nociceptive pathways, such as calcitonin
gene-related peptide (CGRP) and substance P (Vizzard, 2001;
Merrill et al., 2013). Extension of these studies using double
labeling fluorescence or electrophysiological recording has further
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demonstrated that many bladder afferent neurons express recep-
tors and ion channels that function in nociception [e.g., transient
receptor potential (TRP) channels] (Skryma et al., 2011; Avelino
et al., 2013). Together these studies are progressively defining the
functional phenotypes of bladder afferent neurons.
DRG neurons express receptors (GFRα1–3) for three members
of the glial cell line-derived neurotrophic factor (GDNF) family
of ligands (GFL)—GDNF, neurturin, and artemin. Of these, only
the artemin receptor (GFRα3) is associated with the peptidergic
class of C-fiber neurons that is expressed by approximately half
of this population (Orozco et al., 2001; Bespalov and Saarma,
2007; Ernsberger, 2008). These neurotrophic factors have pow-
erful sensitizing actions on nociceptors and in inflamed tissue
contribute to hypersensitivity and hyperalgesia (Elitt et al., 2006;
Malin et al., 2006, 2011; Tanaka et al., 2011). GDNF levels in the
bladder are also increased during bladder inflammation (Vizzard,
2000); to date, the levels of neurturin and artemin have not been
examined here. Many sacral bladder afferent neurons express the
preferred receptors for GDNF and artemin (GFRα1 and GFRα3,
respectively), and these two neuron classes have distinct cen-
tral projection patterns in sacral spinal cord, indicating different
functions (Forrest and Keast, 2008). Following chronic bladder
inflammation, the intensity of GFRα1 immunolabeling increases
in the sacral dorsal horn, potentially due to structural remodel-
ing (e.g., sprouting), increased receptor expression or increased
trafficking of receptor to central terminals (Forrest and Keast,
2008). Together these results indicate these two neurotrophic
factors may be involved in plasticity of sacral visceral afferent
neurons following inflammation but do not identify which types
of bladder afferents are likely to be most influenced by these
factors.
The majority of bladder afferent neurons express estrogen
receptors (ERs); many of these neurons are peptidergic and co-
express TRPV1 (Bennett et al., 2003). Numerous studies have
implicated estrogens in pain modulation e.g., (Robbins et al.,
1990, 1992; Sanoja and Cervero, 2005; Gintzler and Liu, 2012),
including direct attenuation of TRPV1 responses to capsaicin (Xu
et al., 2008). In particular, hormonal status influences bladder
activity, as well as the development and severity of a number
of pelvic visceral pain conditions including interstitial cystitis
(Shea et al., 2000; Johnson and Berkley, 2002; Robinson and
Cardozo, 2003; Dmitrieva and Berkley, 2005;Warren et al., 2011).
Understanding the precise targets of estrogens in bladder sen-
sory pathways is critical to understanding their function and
potentially targeting this mechanism to modulate pain.
The first aim of this study was to define the chemical classes of
lumbar and sacral bladder sensory neurons that express receptors
for two types of endogenous modulators of nociceptor sensitivity,
the GFLs, and estrogens. Our strategy was to use well-described
markers of key functional classes of neurons, including CGRP,
TRPV1 [a marker of nociceptive C-fibers (Julius and Basbaum,
2001)] and NF200 [a marker of primary afferent neurons with
myelinated axons, (Lawson et al., 1993, 1997)]. An additional
outcome of this group of experiments was the first immunohisto-
chemical characterization of myelinated bladder afferent neurons
that have an important role in the micturition reflex (Sengupta
and Gebhart, 1994; Yoshimura et al., 2003; Fowler et al., 2008;
De Groat and Yoshimura, 2009). Our second aim was to iden-
tify and chemically characterize bladder sensory neurons that are
most susceptible to the acutely altered environment of inflamma-
tion induced by CYP; this treatment is associated with acute but
transient urothelial loss, potentially exposing underlying affer-
ent terminals to the luminal environment (Birder, 2011; Birder
et al., 2012). To identify neurons potentially undergoing struc-
tural change in response to this tissue damage, we visualized
expression of the immediate early gene product, ATF-3 (activat-
ing transcription factor-3) in bladder afferent neurons after acute
CYP treatment. ATF-3 can be induced in DRG following axotomy,
application of noxious chemical stimuli and cellular stress (Hai
et al., 1999; Tsujino et al., 2000; Averill et al., 2004; Shortland
et al., 2006; Seijffers et al., 2007; Braz and Basbaum, 2010). Other
studies have demonstrated that ATF-3 can also be up-regulated
in models of joint inflammation and partial urethral obstruc-
tion (Xu et al., 2011). We therefore, investigated if acute bladder
inflammation induces ATF-3 expression in DRGs and, if so, if this
occurred in a particular chemical class.
MATERIALS AND METHODS
ANIMALS
All procedures were approved by the Animal Care and Ethics
Committees of the University of Sydney and Royal North Shore
Hospital, as required by the Australian Code of Practice for
the Care and Use of Animals for Scientific Purposes (National
Health and Medical Research Council of Australia). Adult female
Sprague-Dawley rats (6–10 weeks) were used for these experi-
ments. They were purchased from the Animal Resources Centre
(Murdoch, WA, Australia), and housed under a 12 h light-dark
cycle with free access to food and water. Estrous cycle was not
monitored or controlled in these experiments.
RETROGRADE TRACER INJECTIONS AND ANIMAL TREATMENTS
To identify bladder-projecting afferent neurons in DRGs, the ret-
rograde tracer Fluorogold (FG; Fluorochrome, Englewood, CO;
4% in sterile saline; total<10μl) was injected into ∼8 sites in the
urinary bladder base using an insulin syringe with a 30G needle,
as described previously (Forrest and Keast, 2008). This was per-
formed under isoflurane anaesthesia (3% for induction, 1.5–2%
for maintenance in O2). Animals used only for retrograde trac-
ing studies were perfused with fixative 7 days after surgery (see
below). A second group of animals underwent retrograde trac-
ing and 7 days later acute bladder inflammation was induced.
This was performed by undergoing brief anaesthesia with isoflu-
rane (3%) during injection with a single dose of CYP (75mg/kg
in sterile saline, i.p.) or saline (1ml/kg, i.p.), as described previ-
ously (Corrow and Vizzard, 2007). These rats were perfused with
fixative 24 h later (see below).
TISSUE PREPARATION AND IMMUNOHISTOCHEMISTRY
Rats were heavily anaesthetised with sodium pentobarbitone
(80mg/kg i.p.) and transcardially perfused with 0.9% saline con-
taining 1.25% sodium nitrite and 0.036% heparin, followed by
freshly made 4% paraformaldehyde in 0.1M phosphate buffer
(PB, pH 7.4). DRGs (L1, L2, L6, S1) and the bladder were removed
and post-fixed overnight in the same fixative at 4◦C, then washed
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in 0.1M phosphate buffered saline (PBS, pH 7.2) and stored in
PBS containing 0.1% sodium azide until sectioning.
DRGs were cryoprotected overnight in PBS containing 30%
sucrose and cut on a cryostat into 14μm sections. Sections were
collected onto 0.1% gelatinized slides and distributed between
slides so that sections stained for the same substance were sam-
pled at least 56μm apart. Each block contained two DRGs, each
from the same spinal level, and comprising one each from a saline
and CYP-treated animal. Sections were air-dried, washed in PBS,
and blocked for 1–2 h in PBS containing 10% non-immune horse
serum and 0.1% triton X-100.
Sections were incubated overnight in combinations of anti-
sera, washed, and incubated for 2–3 h in appropriate host-
specific secondaries (Table 1). Each of the primary antibodies
has been characterized extensively in previous studies (Forrest
and Keast, 2008; Kalous et al., 2009; Kiasalari et al., 2010) and
showed general patterns of staining comparable to these earlier
Table 1 | Primary and secondary antibodies used for
immunohistochemistry.
Antigen Host Supplier/catalog number Dilution
PRIMARY ANTIBODIES
ATF-3 Rabbit Santa Cruz Biotechnology
(Scoresby, VIC, Australia);
sc-188
1:500
ED-1 (CD86) Mouse Millipore (Kilsyth, VIC,
Australia); MAB1435
1:1000
CGRP Goat Millipore; 1720-9007 1:2000
CGRP Rabbit Sigma-Aldrich (Castle Hill,
NSW, Australia); C8198
1:5000
ERα Rabbit Affinity Bioreagents
(Scoresby, VIC, Australia);
PA1-308
1:350
ERα Rabbit Millipore; C1355 1:5000
GFRα1 Goat R&D Systems (Minneapolis,
MN); AF560
1:400
GFRα2 Goat R&D Systems; AF429 1:300
GFRα3 Goat R&D Systems; AF2645 1:300
NF200 Mouse Sigma-Aldrich; N0142 1:4000
NOS Rabbit Zymed Laboratories (now
Invitrogen, Mulgrave, VIC,
Australia); 61-7000
1:500
TRPV1 Guinea pig Millipore; AB5566 1:5000
TRPV1 Rabbit Neuromics (Burwood East,
VIC, Australia); RA10110
1:8000
SECONDARY ANTIBODIES
anti-goat Cy3 Donkey Jackson Laboratories;
705-165-147
1:1000
anti-guinea pig FITC Donkey Jackson Laboratories;
706-095-148
1:100
anti-mouse AF488 Donkey Invitrogen; A-21202 1:1000
anti-mouse Cy3 Donkey Jackson Laboratories;
715-165-150
1:2000
anti-rabbit AF488 Donkey Invitrogen; A21206 1:2000
anti-sheep AF488 Donkey Invitrogen; A-11015 1:1000
reports. To identify neurons that could potentially be influ-
enced by GFLs, we used antibodies raised against the preferred
receptors for GDNF (GFRα1), neurturin (GFRα2), and artemin
(GFRα3). In this study, we utilized two different ERα antibod-
ies, the first purchased from Affinity Bioreagents has been used
previously by our laboratory (Bennett et al., 2003), and the
second from Millipore that has been reported to label a dif-
ferent population of neurons (Kiasalari et al., 2010). Here we
have distinguished these two ERα antibodies by their manufac-
turer, i.e., ERα (Affinity) and ERα (Millipore). The antibody
from Affinity was raised against the N-terminal 21 residues of
the receptor, whereas the antibody from Millipore was raised
against the C-terminal 15 residues. According to information sup-
plied by the manufacturers, specificity has been demonstrated
with Western blotting, notably that neither ERα antibody cross-
reacts with the most likely potential cross-reacting receptor, ERβ.
We have previously determined that all ERα immunolabeled in
rat DRG with the ERα (Affinity) antibody is absorbed by the
antigenic peptide, including in neurons that also express ERβ;
(Bennett et al., 2003) data provided by Kiasalari et al. (2010)
on the ERα (Millipore) antibody, has shown patterns of stain-
ing comparable to those demonstrated by that group with in situ
hybridization.
Antibodies were diluted with 0.1M hypertonic PBS (pH 7.2).
All incubations were performed in a humid chamber, in the dark
at room temperature. Slides were cover-slipped with carbonate-
buffered glycerol (pH 8.6).
To confirm acute bladder inflammation, bladder sections
(14μm) from acute CYP-treated animals and controls were pro-
cessed for ED-1, as described for DRG sections. Qualitative assess-
ment showed a pronounced infiltration of ED-1-positive cells
(likely monocytes and macrophages) in the detrusor and mucosa
of acute CYP-treated animals but not in the saline group (not
shown).
QUANTITATION OF NEURONAL POPULATIONS
DRGs were viewed under an Olympus BX51 fluorescence micro-
scope (Olympus Australia, Melbourne, Australia) and counts
made while viewing directly from the microscope. To charac-
terize bladder-projecting neurons, a minimum of 120 nucleated
profiles of FG-labeled neurons were counted from five sections
from each ganglion. Ganglia were classified as “lumbar” if from
spinal levels L1 or L2 and “sacral” if from L6 and S1. These neu-
rons were classified on the basis of their immunoreactivity (IR)
for GFRs, TRPV1, CGRP, ERα (both antibodies), NF200 and
NOS. The percentage of FG neurons expressing each marker or
co-marker was averaged for each DRG in each rat. The arcsine-
transformed data from sacral and lumbar DRGs was compared
using a paired t-test. The number of ATF-3 positive FG-labeled
neurons containing CGRP, NOS, and the GFRs following acute
CYP treatment or saline were compared by performing Tukey’s
multiple comparison post hoc test on arcsine transformed data.
This was used to detect an effect of CYP treatment on the propor-
tion of FG-labeled neurons expressing each of these markers and
a comparison between sacral and lumbar DRGs. In past studies,
sacral DRGs have been more thoroughly characterized so will be
the primary point of reference and data on these neurons will be
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provided first in each of the histograms and in the text. All results
are provided as the mean ± s.e.m. and P < 0.05 was regarded as
statistically significant.
FIGURE PRODUCTION
Eight-bit monochrome images were captured with an RT-SPOT
camera (Diagnostic Instruments, Sterling Heights, MI) and dig-
itized using Image Pro Plus (Media Cybernetics, Silver Spring,
MD). For figure production, only minor adjustments were made
to brightness and contrast in Adobe Photoshop (San Jose, CA)
to best represent the staining as viewed directly under the micro-
scope. Colorized images were produced by pasting monochrome
images into the appropriate color channel of a 24-bit RGB file in
Photoshop; these images were collated and labeled using InDesign
(Adobe Creative Suite 5). FluoroGold labeling was colorized
blue instead of its native color to facilitate viewing of merged
images.
RESULTS
GFRα1 AND GFRα3 WERE EXPRESSED IN MANY TRPV1-IR
BLADDER-PROJECTING NEURONS
FG-labeled neurons were identified in all of the ganglia and we
first quantified how many of these neurons were immunoreactive
for each of CGRP, the GFRs, and TRPV1. TRPV1 is a marker of
polymodal nociceptor neurons that is expressed by the majority
of bladder afferent neurons (Bennett et al., 2003). Previous stud-
ies of DRGs at other spinal levels have shown that the majority of
CGRP-IR neurons express TRPV1 (Kiasalari et al., 2010) and that
GFRα3-IR is expressed in a sub-population of CGRP-IR neurons
(Orozco et al., 2001; Kalous et al., 2009). From these previous
studies we also predicted that GFRα1- and GFRα2-IR would be
found in the non-peptidergic population (Bennett et al., 1998;
Kalous et al., 2007, 2009).
In sacral DRG, 70.6 ± 3.1% of FG-labeled neurons con-
tained TRPV1-IR and 54.2 ± 2.5% contained CGRP-IR (n =
4, Figures 1A,D,E). Expression of each GFR in retrogradely
labeled neurons varied with the type of receptor, with 20.4 ±
1.4% GFRα1-IR, <2% GFRα2-IR and 34.3 ± 3.0% GFRα3-
IR (n = 4, Figures 1A,F–H). Quantification of FG-labeled neu-
rons in lumbar DRG found broadly similar patterns of labeling
(n = 4; Figure 1A), although consistent with previous publica-
tions (Bennett et al., 2003), we found CGRP-IR neurons more
prevalent in lumbar than sacral DRGs (67.7 ± 1.8% lumbar vs.
54.2 ± 2.5% sacral, n = 4, P < 0.001, Figure 1A).
We next investigated the co-expression of GFRα1-, GFRα3-,
and CGRP-IR with TRPV1-IR in bladder afferent neurons
(Figures 1B,C,I,J). This was not performed with GFRα2 as it
was expressed by so few FG-positive neurons. At both spinal
levels, approximately one third of GFRα1-IR bladder affer-
ent neurons contained TRPV1-IR (Figure 1B), but these com-
prised only ∼10% of all TRPV1-IR bladder afferent neurons
(Figure 1C). Almost all GFRα3- and CGRP-IR neurons contained
TRPV1-IR (Figures 1B,I,J). Conversely, approximately half of all
TRPV1-IR bladder neurons contained GFRα3-IR (Figures 1C,I)
and 70–80% contained CGRP-IR (Figures 1C,J). In both sacral
and lumbar DRGs, almost all GFRα3-IR bladder neurons con-
tained CGRP-IR (sacral, 94.3 ± 2.1%; lumbar, 96.7 ± 1.4%;
n = 4) and the majority of CGRP-IR bladder neurons were
GFRα3-IR (sacral, 70.1 ± 2.8%; lumbar, 61.2 ± 2.3%, n = 4).
ERαWAS EXPRESSED IN FUNCTIONALLY DIVERSE POPULATIONS OF
BLADDER SENSORY NEURONS
DRG sections immunostained with either ERα antibody labeled
the nucleus of a subpopulation of neurons; neurons with a
nucleus brighter than the cytoplasm were regarded as ERα-IR.
In some neurons stained with the Affinity antibody, in addi-
tion to ERα-positive nuclei there was weak cytoplasmic stain-
ing. Assessment of FG-labeled neurons labeled with this anti-
body showed that in sacral and lumbar DRGs, 29.6 ± 3.9% and
39.4 ± 1.2%, respectively, were immunoreactive for ERα (n =
5, Figures 2A,B). In these double-stained sections, we found a
similar pattern of expression for GFRs and TRPV1 (Figure 2B)
as described above. However, in this component of the study
we also co-stained for the myelination marker, NF200, and
found that ∼60% of sacral and lumbar FG-labeled neurons were
immunoreactive for NF200 (n = 5, Figures 2A,B).
Using the antibody from Affinity, ERα-IR neurons were then
categorized according to their co-expression with GFRα1, GFRα3,
CGRP, TRPV1, and NF200 (Figures 2C–F). Approximately 40%
of GFRα1-IR FG-labeled neurons in sacral and lumbar DRGs
contained ERα-IR, and these comprised ∼30% of all ERα-IR
neurons. However, a difference between bladder sensory neu-
rons in the sacral and lumbar DRG was revealed with GFRα3
co-labeling—very few sacral GFRα3-IR neurons were ERα-IR,
compared to ∼20% of these neurons being ERα-IR in lumbar
DRG (n = 5, P = 0.01). This difference was also reflected in
the proportion of ERα-IR neurons containing GFRα3-IR (5.8 ±
2.3% sacral vs. 27.3 ± 3.6% lumbar; n = 5, P < 0.001). Using
this same antibody purchased from Affinity, the co-expression
of ERα with TRPV1 and CGRP has previously been reported
in bladder sensory neurons (Bennett et al., 2003). The current
study using this antibody showed similar results, with 20–30%
of all CGRP- and TRPV1-IR bladder sensory neurons in lumbar
and sacral DRG showing ERα-IR. Conversely, ∼30% of ERα-IR
bladder sensory neurons contained CGRP-IR and half contained
TRPV1-IR.
The expression of ERα has not previously been compared
between myelinated and unmyelinated bladder sensory neurons.
Using the same ERα antibody as above (from Affinity) and
immunoreactivity for NF200 to indicate myelination, we found
that in sacral DRGs only ∼25% of myelinated bladder neurons
were labeled for ERα-IR; even fewer (∼15%) of this population
expressed ERα in lumbar DRGs (Figures 2C,D; P = 0.03, n = 5).
When viewing the co-expression from the perspective of the ERα-
positive population of bladder sensory neurons, in sacral DRG
around half of these were myelinated and potentially fewer of
these were myelinated in lumbar DRG (although this did not
quite reach statistical significance; P = 0.05, n = 5).
The ERα antibody obtained from Millipore produced a simi-
lar pattern of IR in the nucleus of DRG neurons as that obtained
by Affinity, however, the Millipore antibody labeled fewer blad-
der afferent neurons. As a proportion of FG-labeled neurons, the
Millipore antibody labeled 17.9 ± 1.8% (sacral) and 13.5 ± 1.5%
(lumbar) of FG neurons, whereas the Affinity antibody labeled
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FIGURE 1 | Distribution of TRPV1-, CGRP-, and GFRα-immunoreactivity
(IR) in bladder sensory neurons. (A) The proportion of bladder sensory
neurons containing TRPV1-, CGRP-, and GFR-(IR) at each spinal level.
Bladder-projecting neurons were identified with the retrograde tracer,
FluoroGold (FG). A higher proportion of FG-labeled neurons contain CGRP-IR
in lumbar than sacral DRGs (∗∗∗P < 0.001). (B) The proportion of GFRα1-,
GFRα3-, and CGRP-IR bladder sensory neurons co-expressing TRPV1-IR. (C)
The proportion of TRPV1-IR bladder sensory neurons co-expressing GFRα1-,
GFRα3-, or CGRP-IR. (D–J): Each row of micrographs comprises images from
the same field, showing immunostaining for one or more markers in
retrogradely-labeled bladder sensory neurons. The first panel shows the
tracer dye, FluoroGold (FG), the second panel shows an immunolabel and the
last panel provides a merged, colorized image. The color of each label in the
merged image is indicated by the color of the text in the relevant
monochrome image. (D–H) Example of FG neurons expressing TRPV1- (D),
CGRP- (E), GFRα1- (F), and GFRα3-IR (H). Very few FG neurons were labeled
for GFRα2 (G). (I, J) Co-expression of GFRα3 with TRPV1 (I) and CGRP (J) in
FG-labeled bladder-projecting neurons. Histograms show the mean ± s.e.m.
(n = 4), analyzed by a paired t-test on arcsine-transformed data. Scale bar in
panel (D) represents 50μm and applies to all micrographs. Arrowheads
indicate examples of retrogradely labeled neurons and their relative location
in matching panels.
29.6 ± 3.9% (sacral) and 39.4 ± 1.2% (lumbar) of bladder neu-
rons (all n = 5). We then wished to determine if this decrease was
due to a failure of the Millipore antibody to stain a particular
population of neurons labeled as ERα by the Affinity antibody;
if so, this could reveal a difference in specificity for a form of the
receptor that is distributed differently between neuronal classes.
These additional studies showed that, in contrast to the
Affinity antibody, the Millipore antibody failed to label ERα in
peptidergic bladder sensory neurons. It was rare to find bladder
sensory neurons that co-expressed ERα with GFRα3- or CGRP-
IR in either lumbar or sacral DRG. However, using the Millipore
antibody, co-expression with GFRα1 in sacral bladder sensory
neurons was observed to a similar degree as with the antibody
purchased from Affinity. Specifically, at this spinal level ∼25%
GFRα1-IR bladder sensory neurons contained ERα-IR, and these
comprised approximately half of all ERα-IR neurons. Lumbar
bladder sensory neurons showed less expression of ERα using
the Millipore antibody, with only ∼5% of GFRα1-IR neurons
containing ERα-IR, and these comprising ∼10% of all ERα-IR
neurons. Further examination of the labeling obtained with these
two antibodies was performed in the context ofmyelination status
(see below).
CHARACTERIZATION OF MYELINATED BLADDER AFFERENT NEURONS
Previous studies have reported that just over half of all blad-
der afferent neurons express the myelination marker, NF200-IR
(Hayashi et al., 2009), but its distribution in different chemical
classes is unknown. NF200 antibody labeled many DRG neurons
with varying intensity, with the largest diameter labeled neurons
having the brightest staining (Figures 3A,B). Many NF200-IR
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FIGURE 2 | Distribution of ERα and GFRs in bladder sensory neurons.
This figure illustrates immunostaining for ERα using the antibody purchased
from Affinity Bioreagents. (A, B) The proportion of sacral (A) and lumbar (B)
bladder-projecting neurons containing ERα-, GFRα1, GFRα3-, CGRP-, TRPV1-,
and NF200-immunoreactivity (IR). (C) The proportion of GFRα1-, GFRα3-,
CGRP-, TRPV1-, and NF200-IR bladder sensory neurons containing ERα-IR. A
higher proportion of GFRα3-IR neurons contained ERα-IR in lumbar vs. sacral
DRGs (∗P = 0.01), whereas a higher proportion of NF200-IR neurons
contained ERα-IR in sacral vs. lumbar DRGS (∗P = 0.03). (D) The proportion
of ERα-IR bladder sensory neurons containing each marker. A higher
proportion of ERα-IR neurons contained GFRα3-IR in lumbar vs. sacral DRGs
(∗∗∗P < 0.001). Data represents the mean ± s.e.m. (n = 5), analyzed by a
paired t-test on arcsine-transformed data. (E) Co-expression of ERα- and
GFRα1-IR in a FluoroGold (FG)-labeled neuron. (F) Co-expression of ERα- and
CGRP-IR in a FG-labeled neuron. Images are shown as monochrome image
sets and the merged colorized image. The color of each label in the merged
image is indicated by the color of the text in the relevant monochrome image.
Scale bar in panel (E) represents 50μm and applies to all images.
Arrowheads indicate examples of retrogradely labeled neurons and their
relative location in matching panels.
axons were also observed running through the DRG. Consistent
with previous reports (Hayashi et al., 2009), we found just
over half of all sacral and lumbar bladder-projecting neurons
contained NF200-IR (54.8 ± 1.6% sacral; 57.3 ± 1.4% lumbar,
n = 3).
We then performed double-labeling studies to determine if
myelinated bladder sensory neurons express nitric oxide syn-
thase (NOS), CGRP, GFRα1, or ERα (using both sources of
ERα antisera). Assessment of FG-labeled neurons in sacral
and lumbar DRG for the other neuronal classes (CGRP,
GFRα1, and ERα) showed that each class comprised both
myelinated (NF200-IR) and unmyelinated (NF200-negative)
neurons, however, their relative distributions between these pop-
ulations differed (Figures 3C,D). When all populations of myeli-
nated neurons were analyzed separately they totaled more than
100% (Figure 3D), as would be expected given that many neu-
rons will actually express more than one of these substances (e.g.,
ERα with CGRP).
NOS activity has been linked to plasticity of visceral affer-
ent pathways and is expressed in some bladder afferent neu-
rons (Vizzard et al., 1995a,b, 1996; Callsen-Cencic and Mense,
1997). NOS-IR was of variable labeling intensity and localized
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FIGURE 3 | Distribution of NF200-immunoreactivity (IR) in bladder
sensory neurons. Data shown here compares two antibodies raised
against ERα, purchased from either Affinity Bioreagents or Millipore.
(A, B) Co-expression of NF200 with NOS (A) and GFRα1 (B) in
bladder-projecting neurons retrogradely labeled with FluoroGold (FG). The
neurons in panel (B) are from the same field of view as Figure 1F.
Images are shown as monochrome image sets and the merged image.
The color of each label in the merged image is indicated by the color of
the text in the relevant monochrome image. Scale bar in panel (A)
represents 50μm and applies to all images. (C) The proportion of NOS-,
CGRP-, GFRα1-, and ERα-IR bladder-projecting neurons containing
NF200-IR. Using the Millipore antibody, a higher proportion of ERα-IR
neurons contain NF200-IR in sacral than lumbar DRGs (∗P = 0.02).
(D) The proportion of NF200-IR bladder afferent neurons containing each
marker. A higher proportion of NF200-IR neurons contain CGRP-IR in
lumbar than sacral DRGs (∗P = 0.02). Using either ERα antibody, a higher
proportion of NF200-IR bladder afferent neurons contain ERα in sacral
compared to lumbar DRGs (∗P = 0.03 for ERα [Affinity], ∗∗P < 0.01 for
ERα [Millipore]). Data represents the mean ± s.e.m. (n = 5), analyzed by
a paired t-test on arcsine-transformed data.
to medium sized neurons. About half of all bladder neurons
contained NOS-IR (sacral, 45.9 ± 1.5%; lumbar, 46.6 ± 3.1%;
Figure 3A, n = 3). This is a much higher basal expression of NOS
than reported previously (Vizzard et al., 1995a,b, 1996; Callsen-
Cencic and Mense, 1997) and may reflect differences between
antisera or in the level of labeling intensity that was regarded as
positive. Just over half of all NOS-IR bladder neurons contained
NF200-IR and, in turn, these comprised almost half of all NF200-
IR neurons (Figures 3A,C,D); this did not vary between lumbar
and sacral DRG.
At each spinal level, ∼40% of CGRP-IR bladder neurons
were NF200-IR (Figure 3C), however, more of these NF200-IR
neurons expressed CGRP in the lumbar than the sacral DRG
(48.3 ± 4.4% lumbar vs. 32.1 ± 2.0% sacral; Figure 3D, P =
0.02, n = 3). Approximately 80% of GFRα1-IR bladder neurons
contained NF200-IR and these comprised ∼40% of all NF200-
IR bladder neurons (Figures 3B–D); this did not vary between
lumbar and sacral DRG.
Expression of ERα relative to myelination status was more
complex, showing differences between spinal levels and between
the two ERα antibodies (Figures 3C,D). Using the antibody from
Affinity, the proportion of ERα-IR bladder neurons containing
NF200-IR may have been higher in sacral than lumbar DRGs; this
was close to reaching statistical significance (n = 5, P = 0.05).
In line with this observation, a higher proportion of NF200-
IR bladder neurons contained ERα-IR in sacral than lumbar
DRGs (n = 5, P = 0.03). Although the ERα antibody obtained
from Millipore labeled a smaller proportion of neurons than the
Affinity antibody, similar patterns of co-expression were observed
relative to NF200. That is, a higher proportion of ERα-IR blad-
der neurons contained NF200-IR in sacral DRGs compared to
lumbar DRGs (n = 5, P = 0.02). A higher proportion of NF200-
IR neurons also contained ERα-IR in sacral than lumbar DRG
(P = 0.02, n = 5).
ACUTE BLADDER INFLAMMATION INDUCED ATF-3 ACTIVATION AND
INCREASED NOS EXPRESSION IN SACRAL BLADDER AFFERENT
NEURONS
FG-labeled neurons were assessed for presence of the transcrip-
tion factor, ATF-3. Following acute CYP treatment there was
a small, but significant induction of ATF-3 in bladder neurons
in sacral DRG (Figure 4A; P = 0.03, n = 3). ATF-3 neurons
were rarely seen in DRG from saline treated animals. We also
observed an increase in the number of neurons expressing NOS-
IR (Figure 4B; P = 0.01; n = 3) compared to control animals,
but there was no effect of CYP on the proportion of bladder sen-
sory neurons labeled for CGRP, GFRα1, or GFRα3 (Figure 4B).
Co-expression studies revealed that ∼80% of ATF-3 nuclei were
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FIGURE 4 | Acute bladder inflammation induced ATF-3 and increased
NOS-IR in sacral bladder sensory neurons. (A) Acute cyclophosphamide
(CYP) treatment caused a small, but significant induction of ATF-3 in sacral
bladder sensory neurons (∗P = 0.03). (B) In sacral DRG, acute CYP
treatment increased the proportion of FG-labeled neurons containing
NOS-IR (∗P = 0.01) but did not affect the prevalence of CGRP-, GFRα1-, or
GFRα3-IR bladder sensory neurons. (C) In lumbar DRG, CYP treatment did
not affect the proportion of lumbar bladder sensory neurons containing
ATF-3. (D) Acute CYP treatment did not affect the proportion of lumbar
bladder sensory neurons with NOS-, CGRP-, GFRα1-, or GFRα3-IR. (E)
Approximately 80% of ATF-3-IR nuclei were found in NOS-IR neurons. Data
represents the mean ± s.e.m. (n = 3), analyzed by a paired t-test on
arcsine-transformed data. Images are shown as monochrome image pairs
and the merged image. The color of each label in the merged image is
indicated by the color of the text in the relevant monochrome image. Scale
bar in the first panel (left) represents 30μm and applies to all images.
found in NOS-IR neurons (Figure 4E). In contrast to sacral blad-
der afferent neurons, acute CYP treatment had no effect on the
expression of ATF-3, NOS-, CGRP-, GFRα1-, or GFRα3-IR in
lumbar FG-labeled neurons (Figures 4C,D).
DISCUSSION
This is the first study to identify the populations of bladder sen-
sory neurons in lumbar and sacral DRG that express receptors
for the GDNF family of neurotrophic factors and estrogens, and
are potentially influenced by these endogenous modulators of
nociception. The results demonstrated that diverse but not iden-
tical groups of neurons express these receptors and some bladder
sensory neurons express both families of receptors. Lumbar and
sacral sensory neurons showed some distinct differences in their
labeling profiles. We also identified a small population of bladder
sensory neurons in sacral DRG that upregulate the injury-related
transcription factor, ATF-3, following acute systemic adminis-
tration of CYP. We propose that these are the neurons most
likely to be damaged and undergoing structural remodeling dur-
ing inflammation. This remodeling may drive the development
of abnormal behavior (spontaneous activity, sensitization) in the
chronic setting.
It has previously been shown that populations of bladder
sensory neurons express receptors for GDNF and artemin (i.e.,
GFRα1 and GFRα3, respectively) (Forrest and Keast, 2008). The
central projections of sacral sensory neurons expressing these
receptors terminate in different locations within the dorsal horn
of the spinal cord, illustrating their distinct roles within micturi-
tion (and potentially nociceptive) circuitry (Forrest and Keast,
2008). By performing double-labeling immunofluorescence, we
have shown that, similar to DRGs from other spinal levels,
these two receptors are associated with different populations of
neurons—GFRα1 with non-peptidergic and GFRα3 with pep-
tidergic neurons (Bennett et al., 1998, 2000; Orozco et al., 2001).
Therefore, if levels of GDNF or artemin increase in disease states
such as chronic inflammation, they would be predicted to influ-
ence different aspects of bladder function. Moreover, GFRα3-
positive are peptidergic so also express the nerve growth factor
receptor, trkA (Averill et al., 1995), increasing the complexity of
possible mechanisms for their peripheral sensitization (Pezet and
Mcmahon, 2006).
Both groups of bladder sensory neurons (GFRα1- and GFRα3-
IR) include neurons that could be considered nociceptive by
their expression of TRPV1. These comprise a minority of the
GFRα1-IR bladder afferents and the majority of GFRα3-IR blad-
der afferents. None of the bladder afferents label for the receptor
of the related neurotrophic factor, neurturin, although many
pelvic autonomic neurons (including bladder motor neurons)
express this receptor (Laurikainen et al., 2000; Wanigasekara
et al., 2004; Wanigasekara and Keast, 2005). It is not known if
GFRα2 is expressed by sensory neurons innervating other pelvic
viscera, although there is functional evidence for its presence
in other populations of afferents (Stucky et al., 2002; Lindfors
et al., 2006; Malin et al., 2006). TRPV1 is generally considered
a marker of polymodal nociceptors (Julius and Basbaum, 2001)
but many TRPV1-IR visceral afferent neurons are not exclusively
involved in nociception and are likely to play a role in nor-
mal autonomic regulation, including the micturition reflex (De
Groat and Yoshimura, 2001, 2009; Robinson and Gebhart, 2008).
For example, intravesical injection of capsaicin into the bladder
decreases the micturition threshold and induces bladder contrac-
tion (Maggi, 1992; Dmitrieva et al., 1997). Some bladder neurons
develop a nociceptive function under inflammatory conditions
(Bjorling et al., 2003; Nazif et al., 2007). At other spinal levels,
GDNF and artemin contribute to nociceptor sensitization and
hyperalgesia (Elitt et al., 2006; Malin et al., 2006, 2011). Artemin
is also likely to contribute to the development and maintenance
of colorectal hypersensitivity (Tanaka et al., 2011). GDNF lev-
els in the bladder are increased during bladder inflammation
(Vizzard, 2000) but the expression of artemin by the rat blad-
der is unknown. Together these results indicate that GDNF and
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artemin may be involved in the sensitization and plasticity of
pelvic visceral pathways.
Many bladder afferent neurons express ERs (Bennett et al.,
2003) and various actions of estrogens have been reported
on these neurons. Estrogens have complex actions on bladder
afferent neurons where they modulate two signaling pathways
involved in neural plasticity and nociceptor sensitization, p38
and extracellular signal-related (ERK) mitogen-activated protein
(MAP) kinase (Cheng and Keast, 2009). Another study (Xu et al.,
2008) has shown that estradiol acts directly on DRG neurons to
reduce TRPV1 activation by capsaicin and suggested that pain
could be influenced by modulation of ERs in DRG neurons.
Here we used two different antibodies, one of which (Affinity
Bioreagents) has been used previously by our laboratory to iden-
tify ERα in bladder sensory neurons in rats (Bennett et al., 2003),
and a second from Millipore that has recently been described in
a study of perineal afferents (Kiasalari et al., 2010). It has been
demonstrated previously that many peptidergic and TRPV1-IR
bladder sensory neurons express ERs (Bennett et al., 2003). In
the current work using the Affinity antibody, we showed that
these receptors were also expressed by some non-peptidergic,
GFRα1-IR neurons and that the majority of ERα-IR neurons are
unmyelinated. These detailed analyses revealed a clear difference
between bladder sensory neurons at different spinal levels, with
ERα only expressed by GFRα 3-IR bladder neurons in the lumbar
but not sacral cord. It will be interesting to determine how estro-
gen exposure influences the function of these different classes of
bladder sensory neurons.
Our use of two different ERα antibodies raises questions about
the nature of the antigen that is being revealed. We found a clear
overlap in the population of bladder sensory neurons identified
by each antibody, but the reagent from Millipore labeled many
fewer neurons and specifically failed to label the peptidergic class
(Kiasalari et al., 2010). It is possible that a particular isoform
of the receptor is not expressed by these neurons. Other pos-
sible explanations for this discrepancy suggested by a previous
study in rats (Kiasalari et al., 2010) include: the bladder affer-
ents may have a distinct ER phenotype compared with perineal
afferents analyzed in the previous study; the earlier study used
maleWistar rats whereas we used female Sprague-Dawley rats; we
used direct labeling using fluorophore conjugated secondary anti-
bodies whereas the previous study used tyramide amplification in
conjunction with the Millipore antibody.
Our immunohistochemical approach also allowed us to distin-
guish between myelinated and unmyelinated neurons. Consistent
with previous studies (Yoshimura et al., 1998; Hayashi et al., 2009;
Russo et al., 2013), we found that over half of all bladder afferent
neurons contained NF200-IR. We predict that these are the Aδ
mechanosensitive neurons with thinly myelinated axons (Lawson
et al., 1993). These neurons are likely to respond to innocuous
stimuli such as normal levels of bladder distension. This is the
first study to define which chemical classes of bladder afferent
neurons are myelinated. Our results indicate that most of the
neuronal types examined in this study comprise a mixture of
myelinated and unmyelinated afferents. The prevalence of myeli-
nated neurons in each group was similar in lumbar and sacral
bladder afferents, with the exception of ERα-IR neurons, where a
higher proportion of these were myelinated in sacral than lumbar
neurons.
In this study, we identified a number of immunohistochemical
differences between lumbar and sacral bladder afferents. It would
be very interesting to determine how these relate to functional
differences. Lumbar and sacral components of bladder sensory
afferents have been previously been distinguished in a number of
ways. Most obviously, sacral but not lumbar afferents are required
for the micturition reflex, and undergo major changes during
inflammation that are thought to contribute to bladder symp-
toms and pain (Yoshimura et al., 2002; Fowler et al., 2008; De
Groat and Yoshimura, 2009). However, lumbar bladder afferents
also become sensitized with inflammation (Mitsui et al., 2001).
Moreover, it has been demonstrated in the mouse that lumbar
and sacral bladder afferents terminate in different tissues within
the bladder and can be activated with different stimuli (Xu and
Gebhart, 2008). A similar body of information does not yet exist
for the rat bladder, but it would be interesting to define the
sources of termination within the bladder wall of each neuronal
population studied here. At present there are no unique markers
for these spatially distinct groups of axons.
In the current study, we utilized ATF-3 expression to iden-
tify populations of bladder afferent neurons that were likely to
be injured and undergoing structural remodeling during acute
bladder inflammation. These were observed only in sacral DRG,
where they comprised a minor class (<10%) of bladder afferent
neurons. The absence of ATF-3 from lumbar DRG may indicate
that these neurons do not change in response to CYP or that
their terminals are more distant from the remodeling urothe-
lium. We chose ATF-3 for this study on the basis of a previous
study that observed ATF-3 induction in sensory neurons follow-
ing injection of noxious irritants into the hindpaw (Braz and
Basbaum, 2010). Our result is also consistent with reports of
ATF-3 induction in lumbar DRGs by mono-iodoacetate-induced
osteoarthritis (Ivanavicius et al., 2007), a model of joint in inflam-
mation that produces concurrent axonal damage required to drive
ATF-3 induction. In our study, a possible explanation for the ATF-
3 induction is that CYP metabolism to acrolein causes a rapid
destruction of the urothelium, allowing toxic substances in urine
to impact on the activity and structure of suburothelial axons.
These axons could potentially be sensitized and contribute to
altered reflex behaviors during inflammation. However, it should
be noted that CYP has additional properties and systemic effects
(e.g., immunosuppression) that were not examined in this study
and could contribute to our results. Nevertheless, the acute-
ness of the ATF-3 upregulation and its typical association with
neuronal injury, provide strong support for involvement of a
bladder-related mechanism, such as urothelial damage.
We also found that acute CYP induced an increase in NOS
expression in some sacral (but not lumbar) bladder afferents.
This raises the possibility that NOS upregulation is occurring
in the ATF-3-IR neurons. Rapid up-regulation of NOS in DRGs
has been reported previously following CYP (Vizzard et al.,
1996) or intra-vesical mustard oil (Callsen-Cencic and Mense,
1997). Nitrergic activity in the spinal cord has been implicated
in bladder hyperactivity following acute inflammation (Kakizaki
and De Groat, 1996), but peripheral actions of increased nitric
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oxide synthesis should also be considered. Our results are also
consistent with an increase of calcium-dependent NOS activity
in spinal cord in association with CYP-induced bladder hyper-
reflexia (Lagos and Ballejo, 2004).We did not see an acute effect of
CYP treatment on expression of other neuronal markers (CGRP,
GFRs) but it should be recognized that by assessing only the
proportion of neurons expressing a certain substance, we may
fail to see smaller changes in expression. Moreover, we did not
assess neuronal size, which could have potentially been altered
by inflammation and, if changing, confound our sampling of
neurons for quantitation.
In conclusion, we have defined for the first time the bladder
sensory neurons that express receptors for GDNF, artemin, and
estrogens. We have also provided a detailed characterization of
myelinated bladder afferents. The complexity and heterogeneity
of bladder sensory neurons is reflected at both lumbar and sacral
levels but not identical in each. Our study has also identified a
sub-population of NOS-IR sacral sensory neurons that are likely
to be undergoing structural remodeling during acute inflamma-
tion of the bladder. Together these results contribute to increased
understanding of the neurons that are known to be involved in
pain modulation and hyperreflexia during inflammation.
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